Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.66
0.0452.80%
Last update: Dec 15, 11:31 AM
Comments
Loading...
Autolus Therapeutics (AUTL) Stock Price, Quote, News & History
AUTLNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ:AUTL) through any online brokerage.
Who are Autolus Therapeutics (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: Galectin Therapeutics Inc (NASDAQ:GALT), Monopar Therapeutics Inc (NASDAQ:MNPR), Immuneering Corp (NASDAQ:IMRX), PepGen Inc (NASDAQ:PEPG) and Altimmune Inc (NASDAQ:ALT).
What is the forecast, or price target, for Autolus Therapeutics (AUTL) stock?
Autolus Therapeutics has a consensus price target of $9.27.
What is the current price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $1.655 last updated December 15, 2025 at 11:31 AM EST.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics does not have any upcoming earnings scheduled.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
